Novel Constrain-Based Modeling approaches for the identification of metabolic drug targets in cancer.
Metabolic reprogramming has been defined to be a hallmark of cancer. One major question in cancer research is how to exploit these metabolic alterations for the identification of novel therapeutic strategies. With the outbreak of high throughput –omics data and the advances in genomics, novel holist...
| 主要な著者: | , |
|---|---|
| フォーマット: | info:eu-repo/semantics/doctoralThesis |
| 言語: | eng |
| 出版事項: |
Sevicio de Publicaciones. Universidad de Navarra
2020
|
| 主題: | |
| オンライン･アクセス: | https://hdl.handle.net/10171/58697 |